In uterine leiomyomas, MED12 gene exon 2 mutations impair the normal function of the mediator complex, a key transcriptional regulator, leading to dysregulated transcriptome that promotes tumor growth (“gain of function”). This evidence concerns the gene MED12 and uterine corpus leiomyoma.